Cable Hill Partners, LLC Matinas Bio Pharma Holdings, Inc. Transaction History

Cable Hill Partners, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 06, 2019	SELL	$0.79 - $1.11 $790 - $1,110	-1,000 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$0.6 - $1.41 $5,400 - $12,690	-9,000 Reduced 90.0%	1,000 $1,000
Q4 2018 Feb 12, 2019	BUY	$0.53 - $1.11 $5,300 - $11,100	10,000 New	10,000 $6,000

2.74M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $139M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cable Hill Partners, LLC with notifications on news.